Physician profile
Wei Chen
NPI 1245630722
$8,113.33
in general payments reported to CMS, 2019-2025
59 companies · $2,694 in 2025
The $2,694 reported for 2025 was more than what 96% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $838 · 2022: $824 · 2023: $1,548 · 2024: $2,210 · 2025: $2,694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,062 · Education: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,062.17 |
| Education | $389.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $600.28 | 2021-2025 | |
| Incyte Corporation | $591.14 | 2021-2025 | Jakafi, Pemazyre, Monjuvi |
| Astrazeneca Pharmaceuticals LP | $590.23 | 2021-2025 | Calquence, Lynparza, Enhertu |
| Janssen Biotech, INC. | $506.82 | 2021-2025 | Rybrevant, Carvykti, Imbruvica |
| Puma Biotechnology, INC. | $405.69 | 2023-2025 | |
| Astellas Pharma US INC | $399.84 | 2023-2025 | Xtandi, Xospata |
| Merck Sharp & Dohme LLC | $303.66 | 2021-2025 | Keytruda, Welireg, Keytruda Qlex |
| Eisai INC. | $272.99 | 2022-2025 | |
| Sobi, INC | $253.57 | 2022-2025 | |
| Genentech USA, INC. | $251.58 | 2021-2025 | Itovebi, Phesgo, Columvi |
| Takeda Pharmaceuticals U.S.A., INC. | $239.88 | 2022-2025 | Fruzaqla, Iclusig |
| Celgene Corporation | $224.98 | 2021-2025 | Reblozyl |
| Seagen INC. | $207.49 | 2021-2023 | Adcetris |
| Exelixis INC. | $203.40 | 2023-2025 | Cabometyx |
| Lilly USA, LLC | $203.18 | 2021-2024 | Verzenio, Jaypirca, Retevmo |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.